Cytokinetics to present new findings on Aficamten and hypertrophic cardiomyopathy at ACC 2025
Cytokinetics, Incorporated announced five presentations related to aficamten, an investigational cardiac myosin inhibitor, and hypertrophic cardiomyopathy (HCM), at the American College of Cardiology (ACC) Annual Scientific Session &… read more.
